March 17, 2018 8:17 PM ET


Company Overview of AgeX Therapeutics, Inc.

Key Executives for AgeX Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Michael D. West 58 RelationshipsPresident, CEO & Director64
Russell L. Skibsted No RelationshipsChief Financial Officer58
Aubrey D. N. J. de Grey BA,MA,Ph.D.75 RelationshipsVice-President of New Technology Discovery--

AgeX Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Michael D. West 58 RelationshipsBioTime, Inc.64
Alfred D. Kingsley J.D. 37 RelationshipsGreenway Partners LP74
Michael H. Mulroy 15 RelationshipsAsterias Biotherapeutics, Inc.51
View All Board Members

AgeX Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
AgeX Therapeutics, Inc. CEO Compensation
Industry Average


Biocon Limited Announces Executive Changes
March 02, 2018 1:19 PM ET
Unum Therapeutics Inc. Appoints Christiana Stamoulis to the Additional Role of President
March 02, 2018 1:00 PM ET
Unum Therapeutics Inc. Appoints Karen J. Ferrante and Robert J. Perez to its Board of Directors
March 02, 2018 1:00 PM ET
Mersana Therapeutics, Inc. Announces the Resignation of Donald A. Bergstrom as Chief Medical Officer, Effective as of March 31, 2018
March 02, 2018 12:31 PM ET
Stanley A. Plotkin to Step Down from the Board of Directors of Dynavax Technologies Corporation
March 02, 2018 11:30 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact AgeX Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at